91 related articles for article (PubMed ID: 20374707)
1. The roles and action mechanisms of p160/SRC coactivators and the ANCCA coregulator in cancer.
Hsia EY; Zou JX; Chen HW
Prog Mol Biol Transl Sci; 2009; 87():261-98. PubMed ID: 20374707
[TBL] [Abstract][Full Text] [Related]
2. Deregulated E2F and the AAA+ coregulator ANCCA drive proto-oncogene ACTR/AIB1 overexpression in breast cancer.
Hsia EY; Kalashnikova EV; Revenko AS; Zou JX; Borowsky AD; Chen HW
Mol Cancer Res; 2010 Feb; 8(2):183-93. PubMed ID: 20124470
[TBL] [Abstract][Full Text] [Related]
3. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
Zhang H; Stephens LC; Kumar R
Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
[TBL] [Abstract][Full Text] [Related]
4. The role of STATs in transcriptional control and their impact on cellular function.
Bromberg J; Darnell JE
Oncogene; 2000 May; 19(21):2468-73. PubMed ID: 10851045
[TBL] [Abstract][Full Text] [Related]
5. HOXC8 inhibits androgen receptor signaling in human prostate cancer cells by inhibiting SRC-3 recruitment to direct androgen target genes.
Axlund SD; Lambert JR; Nordeen SK
Mol Cancer Res; 2010 Dec; 8(12):1643-55. PubMed ID: 21047772
[TBL] [Abstract][Full Text] [Related]
6. Regulation of SRC family coactivators by post-translational modifications.
Li S; Shang Y
Cell Signal; 2007 Jun; 19(6):1101-12. PubMed ID: 17368849
[TBL] [Abstract][Full Text] [Related]
7. Steroid receptor coactivator-3 and activator protein-1 coordinately regulate the transcription of components of the insulin-like growth factor/AKT signaling pathway.
Yan J; Yu CT; Ozen M; Ittmann M; Tsai SY; Tsai MJ
Cancer Res; 2006 Nov; 66(22):11039-46. PubMed ID: 17108143
[TBL] [Abstract][Full Text] [Related]
8. Chromatin loading of E2F-MLL complex by cancer-associated coregulator ANCCA via reading a specific histone mark.
Revenko AS; Kalashnikova EV; Gemo AT; Zou JX; Chen HW
Mol Cell Biol; 2010 Nov; 30(22):5260-72. PubMed ID: 20855524
[TBL] [Abstract][Full Text] [Related]
9. SRC-3 has a role in cancer other than as a nuclear receptor coactivator.
Ma G; Ren Y; Wang K; He J
Int J Biol Sci; 2011; 7(5):664-72. PubMed ID: 21647249
[TBL] [Abstract][Full Text] [Related]
10. The p160 family coactivators regulate breast cancer cell proliferation and invasion through autocrine/paracrine activity of SDF-1alpha/CXCL12.
Kishimoto H; Wang Z; Bhat-Nakshatri P; Chang D; Clarke R; Nakshatri H
Carcinogenesis; 2005 Oct; 26(10):1706-15. PubMed ID: 15917309
[TBL] [Abstract][Full Text] [Related]
11. Effect of low-dose tamoxifen on steroid receptor coactivator 3/amplified in breast cancer 1 in normal and malignant human breast tissue.
Haugan Moi LL; Hauglid Flågeng M; Gandini S; Guerrieri-Gonzaga A; Bonanni B; Lazzeroni M; Gjerde J; Lien EA; DeCensi A; Mellgren G
Clin Cancer Res; 2010 Apr; 16(7):2176-86. PubMed ID: 20332317
[TBL] [Abstract][Full Text] [Related]
12. SRC-3 is required for prostate cancer cell proliferation and survival.
Zhou HJ; Yan J; Luo W; Ayala G; Lin SH; Erdem H; Ittmann M; Tsai SY; Tsai MJ
Cancer Res; 2005 Sep; 65(17):7976-83. PubMed ID: 16140970
[TBL] [Abstract][Full Text] [Related]
13. ACTR/AIB1/SRC-3 and androgen receptor control prostate cancer cell proliferation and tumor growth through direct control of cell cycle genes.
Zou JX; Zhong Z; Shi XB; Tepper CG; deVere White RW; Kung HJ; Chen H
Prostate; 2006 Oct; 66(14):1474-86. PubMed ID: 16921507
[TBL] [Abstract][Full Text] [Related]
14. Mice lacking the amplified in breast cancer 1/steroid receptor coactivator-3 are resistant to chemical carcinogen-induced mammary tumorigenesis.
Kuang SQ; Liao L; Wang S; Medina D; O'Malley BW; Xu J
Cancer Res; 2005 Sep; 65(17):7993-8002. PubMed ID: 16140972
[TBL] [Abstract][Full Text] [Related]
15. The role of steroid receptor coactivator-3 (SRC-3) in human malignant disease.
Gojis O; Rudraraju B; Alifrangis C; Krell J; Libalova P; Palmieri C
Eur J Surg Oncol; 2010 Mar; 36(3):224-9. PubMed ID: 19716257
[TBL] [Abstract][Full Text] [Related]
16. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
[TBL] [Abstract][Full Text] [Related]
17. Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers.
Sabbah M; Emami S; Redeuilh G; Julien S; Prévost G; Zimber A; Ouelaa R; Bracke M; De Wever O; Gespach C
Drug Resist Updat; 2008; 11(4-5):123-51. PubMed ID: 18718806
[TBL] [Abstract][Full Text] [Related]
18. Expression levels of estrogen receptor-alpha, estrogen receptor-beta, coactivators, and corepressors in breast cancer.
Kurebayashi J; Otsuki T; Kunisue H; Tanaka K; Yamamoto S; Sonoo H
Clin Cancer Res; 2000 Feb; 6(2):512-8. PubMed ID: 10690532
[TBL] [Abstract][Full Text] [Related]
19. A widely expressed transcription factor with multiple DNA sequence specificity, CTCF, is localized at chromosome segment 16q22.1 within one of the smallest regions of overlap for common deletions in breast and prostate cancers.
Filippova GN; Lindblom A; Meincke LJ; Klenova EM; Neiman PE; Collins SJ; Doggett NA; Lobanenkov VV
Genes Chromosomes Cancer; 1998 May; 22(1):26-36. PubMed ID: 9591631
[TBL] [Abstract][Full Text] [Related]
20. Interaction and functional cooperation of the cancer-amplified transcriptional coactivator activating signal cointegrator-2 and E2F-1 in cell proliferation.
Kong HJ; Yu HJ; Hong S; Park MJ; Choi YH; An WG; Lee JW; Cheong J
Mol Cancer Res; 2003 Nov; 1(13):948-58. PubMed ID: 14638867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
